PEOPLE ON THE MOVE
Abzena
Biomanufacturer Abzena has appointed Jim Mills as VP, Technical Operations.
The company, which provides development services to biopharmaceutical makers, comprises subsidiaries PolyTherics, which makes antibody drug conjugates and Antitope, which deals with assays, protein engineering, and cell line manufacture.
Mills will be a member of Abzena’s Executive Management Team, reporting to CEO John Burt. Mill was most recently the CEO of Cantab Biopharmaceuticals, which he joined in 1997. He rose from process development roles to Director of Operations following the acquisition of Cantab by Xenova in 2007, becoming CEO in 2010 when the company was taken over by Celtic Pharma Holdings.